Boundless Bio, Inc.
BOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $49 | $0 | $0 | $0 |
| - Cash | $27 | $24 | $11 | $34 |
| + Debt | $48 | $2 | $5 | $0 |
| Enterprise Value | $70 | -$22 | -$6 | -$34 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$64 | -$54 | -$46 | -$25 |
| % Margin | – | – | – | – |
| Net Income | -$65 | -$49 | -$46 | -$25 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.85 | -2.22 | -2.06 | -1.13 |
| % Growth | -73.4% | -7.8% | -82.3% | – |
| Operating Cash Flow | -$61 | -$47 | -$40 | -$23 |
| Capital Expenditures | -$3 | -$1 | -$1 | -$2 |
| Free Cash Flow | -$63 | -$47 | -$41 | -$25 |